Nosocomial COVID-19 Rare During Height of Pandemic
THURSDAY, Sept. 10, 2020 (HealthDay News) — During the height of the pandemic, the incidence...
Read More
FDA / Research
Children’s Hospital, ICU Admission Rates Similar for COVID-19, Flu
WEDNESDAY, Sept. 9, 2020 (HealthDay News) — Among children with COVID-19 or seasonal...
Read More
Median of 36 Days Found From COVID-19 Symptom Onset to Viral Clearance
WEDNESDAY, Sept. 9, 2020 (HealthDay News) — The median time from COVID-19 symptom onset to...
Read More
The Effect of COVID-19 in Patients with Thoracic Malignancies
Thoracic malignancies or thoracic cancers include lung cancers, thymic malignancies, lung...
Read More
AstraZeneca Covid-19 Vaccine Trial Halted by Adverse Event Report
UK participant said to have developed acute transverse myelitis ©Wirestock — stock.adobe.com...
Read MoreWill Labor Day Weekend Bring Another Holiday COVID Surge?
Epidemiologists are having a hard time predicting whether Labor Day will be like the Fourth of July and Memorial Day, when celebrations fanned the flames in coronavirus hot spots around the South and West.
Read More
Covid-19: The Who, What, and When of Vaccines
Has politics spoiled the hope for a Covid-19 vaccine? One possible adverse effect of infection...
Read More
Livedoid and Purpuric Skin Eruptions with Coagulopathy for COVID-19
The coronavirus disease 2019 (COVID-19) has been associated with several cardiovascular...
Read More
Depression Symptoms Rise During Covid-19 Pandemic
Burden falls harder on people already at increased risk The Covid-19 pandemic is tied to a high...
Read More
Health Officials Worry Nation’s Not Ready for COVID-19 Vaccine
As the nation awaits a vaccine to end the pandemic, local health departments say they lack the staff, money, tools ― and a unified plan ― to distribute, administer and track millions of vaccines, most of which will require two doses. Dozens of doctors, nurses and health officials interviewed by KHN and The Associated Press expressed their concern and frustration over federal shortcomings.
Read More
Dozens of U.S. Hospitals Poised to Defy FDA’s Directive on COVID Plasma
The FDA, under pressure from the Trump administration, has authorized broader use of convalescent plasma for emergency treatment in COVID patients. But several major hospitals are resisting, saying they’ll opt instead to use the scarce resource to complete a clinical trial.
Read More
Fauci Says COVID Vaccine Trials Could End Early If Results Are Overwhelming
The nation’s top infectious disease official is confident that an independent panel will base vaccine approval on science, not politics.
Read More
Covid-19: Metabolic Syndrome Strong Risk Factor for Death
Cluster of high BP, diabetes and obesity linked to 4-fold greater mortality risk from Covid-19...
Read MoreAnother COVID Mystery: Patients Survive Ventilator, But Linger in a Coma
Doctors are diagnosing a new stage of COVID-19 recovery: patients who take much longer than usual to regain consciousness after coming off a ventilator. And a growing number of doctors are worried some patients aren’t being given the time they need to wake up.
Read More
Covid-19: AMA Demands Complete Transparency from FDA on Vaccine Data
Madera calls for cooperation in instilling vaccine confidence CHICAGO — The American Medical...
Read More
Molecular Testing Strategies for COVID-19
With COVID-19 inflicting substantial damage to the humankind, the WHO has encouraged countries to...
Read More
Covid-19: Hospitalization Risk No Greater for Patients with Lupus, IA
Arthritis patients taking steroids did have higher risk for hospitalization, but not those on...
Read More
Covid-19: Hahn Tweets a Mea Culpa on Convalescent Plasma Claim
FDA commissioner raises ire of scientific community in numbers mix up FDA Commissioner Stephen...
Read More
Many People of Color, Immigrants Among 1,080 US Health Workers Lost to COVID
The Guardian and KHN release new figures showing that, among health care workers, a disproportionate number of immigrants and minorities have died.
Read More
They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to Pharma
Advocates of cheap and widely available vaccines thought the pandemic might change business as usual. They were wrong.
Read More